086450 — DongKook Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapNeutral

Market Cap
KR₩854bn
Enterprise Value
KR₩904bn
Revenue
KR₩927bn

Annual balance sheet for DongKook Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	168,929	103,955	93,710	88,704	126,402
Net Total Accounts Receivable
Net Total Receivables	139,496	151,600	179,061	209,391	251,287
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	420,226	385,321	419,197	470,007	565,396
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	234,941	263,355	272,705	299,459	312,222
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	750,076	768,330	839,535	953,165	1,062,896
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	242,601	198,539	231,153	232,692	267,414
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	295,510	266,391	294,841	349,688	399,155
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	454,566	501,939	544,694	603,477	663,741
Total Liabilities & Shareholders' Equity	750,076	768,330	839,535	953,165	1,062,896
Total Common Shares Outstanding
Total Preferred Shares Outstanding